Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Transitional Cell × Nivolumab × Clear all

Phase

Phase 2 13 Phase 1 13 Phase 1/2 8 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Melanoma 20 Carcinoma, Renal Cell 12 Stomach Neoplasms 8 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Brain Neoplasms 5 Mesothelioma 4 Kidney Neoplasms 4 Carcinoma, Hepatocellular 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Various Advanced Cancer 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Mesothelioma, Malignant 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma 2 Anus Neoplasms 2 Adenocarcinoma 2 von Hippel-Lindau Disease 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thoracic Neoplasms 1

Interventions

Mitomycin 9 Gemcitabine 9 Cisplatin 8 Carboplatin 7 pembrolizumab 5 toripalimab 3 avelumab 3 atezolizumab 3 Docetaxel 3 Platinum 2 Paclitaxel 2 Injections 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 valrubicin 1 tislelizumab 1 sacituzumab govitecan 1 lenvatinib 1 epacadostat 1 durvalumab 1 dodecyl maltoside 1 disitamab vedotin 1 Vitamin B 12 1 Taxes 1 Standard of Care 1 Specimen Handling 1 Ramucirumab 1 Polysorbates 1 Pemetrexed 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04637594 2025-01-15

IMAGINE

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡